speb/financial-data huggingface dataset:
JQC balance_sheet (annual, 2022-07-31) — Share Issued: 136199996.00
JQC balance_sheet (annual, 2022-07-31) — Stockholders Equity: 827030571.00
JQC balance_sheet (annual, 2022-07-31) — Tangible Book Value: 827030571.00
JQC income_statement (annual, 2022-07-31) — Tax Effect Of Unusual Items: 0.00
JQC income_statement (annual, 2022-07-31) — Tax Rate For Calcs: 0.00
JQC balance_sheet (annual, 2022-07-31) — Total Assets: 1409654499.00
JQC balance_sheet (annual, 2022-07-31) — Total Capitalization: 1216009950.00
JQC balance_sheet (annual, 2022-07-31) — Total Debt: 388979379.00
JQC balance_sheet (annual, 2022-07-31) — Total Equity Gross Minority Interest: 827030571.00
JQC balance_sheet (annual, 2022-07-31) — Total Liabilities Net Minority Interest: 582623928.00
JQC income_statement (annual, 2023-07-31) — +Operating Expense: 2361231.00
JQC income_statement (annual, 2023-07-31) — +Total Revenue: 40347957.00
JQC balance_sheet (annual, 2023-07-31) — Accounts Payable: 34638193.00
JQC balance_sheet (annual, 2023-07-31) — Additional Paid In Capital: 1148545187.00
JQC balance_sheet (annual, 2023-07-31) — Available For Sale Securities: 32053047.00
JQC income_statement (annual, 2023-07-31) — Basic Average Shares: 136896744.00
JQC income_statement (annual, 2023-07-31) — Basic EPS: 0.28
JQC cash_flow (annual, 2023-07-31) — Beginning Cash Position: 2077935.00
JQC balance_sheet (annual, 2023-07-31) — Capital Stock: 1356093.00
JQC balance_sheet (annual, 2023-07-31) — Cash And Cash Equivalents: 3471201.00
JQC balance_sheet (annual, 2023-07-31) — Cash Cash Equivalents And Federal Funds Sold: 3471201.00
JQC cash_flow (annual, 2023-07-31) — Cash Dividends Paid: -74313060.00
JQC balance_sheet (annual, 2023-07-31) — Cash Financial: 3471201.00
JQC cash_flow (annual, 2023-07-31) — Change In Accrued Expense: -132490.00
JQC cash_flow (annual, 2023-07-31) — Change In Other Current Assets: -354982.00
JQC cash_flow (annual, 2023-07-31) — Change In Other Current Liabilities: -521516.00
JQC cash_flow (annual, 2023-07-31) — Change In Payable: -18020383.00
JQC cash_flow (annual, 2023-07-31) — Change In Receivables: 31430742.00
JQC cash_flow (annual, 2023-07-31) — Change In Working Capital: 12401371.00
JQC cash_flow (annual, 2023-07-31) — Changes In Cash: 1393266.00
JQC balance_sheet (annual, 2023-07-31) — Common Stock: 1356093.00
JQC cash_flow (annual, 2023-07-31) — Common Stock Dividend Paid: -74313060.00
JQC balance_sheet (annual, 2023-07-31) — Common Stock Equity: 789957555.00
JQC income_statement (annual, 2023-07-31) — Diluted Average Shares: 136896744.00
JQC income_statement (annual, 2023-07-31) — Diluted EPS: 0.28
JQC income_statement (annual, 2023-07-31) — Diluted NI Availto Com Stockholders: 37986726.00
JQC cash_flow (annual, 2023-07-31) — Dividend Paid Cfo: 0.00
JQC cash_flow (annual, 2023-07-31) — End Cash Position: 3471201.00
JQC balance_sheet (annual, 2023-07-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1261922868.00
JQC cash_flow (annual, 2023-07-31) — Financing Cash Flow: -108713060.00
JQC cash_flow (annual, 2023-07-31) — Free Cash Flow: 110106326.00
JQC cash_flow (annual, 2023-07-31) — Gain Loss On Investment Securities: 66626976.00
JQC income_statement (annual, 2023-07-31) — Gain On Sale Of Security: -77125772.00
JQC income_statement (annual, 2023-07-31) — General And Administrative Expense: 2357627.00
JQC income_statement (annual, 2023-07-31) — Interest Expense: 24897726.00
JQC income_statement (annual, 2023-07-31) — Interest Income: 106484359.00
JQC balance_sheet (annual, 2023-07-31) — Invested Capital: 1144620557.00
JQC balance_sheet (annual, 2023-07-31) — Investmentin Financial Assets: 1293975915.00
JQC balance_sheet (annual, 2023-07-31) — Investments And Advances: 1293975915.00
JQC cash_flow (annual, 2023-07-31) — Issuance Of Debt: 8300000.00
JQC balance_sheet (annual, 2023-07-31) — Long Term Debt And Capital Lease Obligation: 354663002.00
JQC cash_flow (annual, 2023-07-31) — Long Term Debt Issuance: 8300000.00
JQC cash_flow (annual, 2023-07-31) — Long Term Debt Payments: -42700000.00
JQC balance_sheet (annual, 2023-07-31) — Net Debt: 351191801.00
JQC income_statement (annual, 2023-07-31) — Net Income: 37986726.00
JQC income_statement (annual, 2023-07-31) — Net Income Common Stockholders: 37986726.00
JQC income_statement (annual, 2023-07-31) — Net Income Continuous Operations: 37986726.00
JQC income_statement (annual, 2023-07-31) — Net Income From Continuing And Discontinued Operation: 37986726.00
JQC income_statement (annual, 2023-07-31) — Net Income From Continuing Operation Net Minority Interest: 37986726.00
JQC cash_flow (annual, 2023-07-31) — Net Income From Continuing Operations: 37986726.00
JQC income_statement (annual, 2023-07-31) — Net Income Including Noncontrolling Interests: 37986726.00
JQC income_statement (annual, 2023-07-31) — Net Interest Income: 81586633.00
JQC cash_flow (annual, 2023-07-31) — Net Issuance Payments Of Debt: -34400000.00
JQC cash_flow (annual, 2023-07-31) — Net Long Term Debt Issuance: -34400000.00
JQC cash_flow (annual, 2023-07-31) — Net Other Financing Charges: 0.00
JQC balance_sheet (annual, 2023-07-31) — Net Tangible Assets: 789957555.00
JQC income_statement (annual, 2023-07-31) — Normalized Income: 37986726.00
JQC cash_flow (annual, 2023-07-31) — Operating Cash Flow: 110106326.00
JQC income_statement (annual, 2023-07-31) — Operating Revenue: 40347957.00
JQC balance_sheet (annual, 2023-07-31) — Ordinary Shares Number: 136199996.00
JQC cash_flow (annual, 2023-07-31) — Other Non Cash Items: -6908747.00
JQC income_statement (annual, 2023-07-31) — Other Operating Expenses: 3604.00
JQC balance_sheet (annual, 2023-07-31) — Payables: 34638193.00
JQC balance_sheet (annual, 2023-07-31) — Preferred Securities Outside Stock Equity: 139362070.00
JQC income_statement (annual, 2023-07-31) — Pretax Income: 37986726.00
JQC balance_sheet (annual, 2023-07-31) — Receivables: 21940671.00
JQC cash_flow (annual, 2023-07-31) — Repayment Of Debt: -42700000.00
JQC balance_sheet (annual, 2023-07-31) — Retained Earnings: -359943725.00
JQC income_statement (annual, 2023-07-31) — Selling General And Administration: 2357627.00
JQC balance_sheet (annual, 2023-07-31) — Share Issued: 136199996.00
JQC balance_sheet (annual, 2023-07-31) — Stockholders Equity: 789957555.00
JQC balance_sheet (annual, 2023-07-31) — Tangible Book Value: 789957555.00
JQC income_statement (annual, 2023-07-31) — Tax Effect Of Unusual Items: 0.00
JQC income_statement (annual, 2023-07-31) — Tax Rate For Calcs: 0.21
JQC balance_sheet (annual, 2023-07-31) — Total Assets: 1320325269.00
JQC balance_sheet (annual, 2023-07-31) — Total Capitalization: 1144620557.00
JQC balance_sheet (annual, 2023-07-31) — Total Debt: 354663002.00
JQC balance_sheet (annual, 2023-07-31) — Total Equity Gross Minority Interest: 789957555.00
JQC balance_sheet (annual, 2023-07-31) — Total Liabilities Net Minority Interest: 530367714.00
JQC income_statement (annual, 2024-07-31) — +Operating Expense: 2360248.00
JQC income_statement (annual, 2024-07-31) — +Total Revenue: 100431419.00
JQC balance_sheet (annual, 2024-07-31) — Accounts Payable: 36578090.00
JQC balance_sheet (annual, 2024-07-31) — Additional Paid In Capital: 1138816888.00
JQC balance_sheet (annual, 2024-07-31) — Available For Sale Securities: 36632299.00
JQC income_statement (annual, 2024-07-31) — Basic Average Shares: 137444748.00
JQC income_statement (annual, 2024-07-31) — Basic EPS: 0.71
JQC cash_flow (annual, 2024-07-31) — Beginning Cash Position: 3471201.00
JQC balance_sheet (annual, 2024-07-31) — Capital Stock: 1356093.00
JQC balance_sheet (annual, 2024-07-31) — Cash And Cash Equivalents: 277536.00
JQC balance_sheet (annual, 2024-07-31) — Cash Cash Equivalents And Federal Funds Sold: 277536.00
JQC cash_flow (annual, 2024-07-31) — Cash Dividends Paid: -86167108.00
JQC balance_sheet (annual, 2024-07-31) — Cash Financial: 277536.00
JQC cash_flow (annual, 2024-07-31) — Change In Accrued Expense: -347600.00
JQC cash_flow (annual, 2024-07-31) — Change In Other Current Assets: 633909.00
JQC cash_flow (annual, 2024-07-31) — Change In Other Current Liabilities: -45061.00
JQC cash_flow (annual, 2024-07-31) — Change In Payable: 1106082.00
JQC cash_flow (annual, 2024-07-31) — Change In Receivables: -3291149.00
JQC cash_flow (annual, 2024-07-31) — Change In Working Capital: -1943819.00
JQC cash_flow (annual, 2024-07-31) — Changes In Cash: -3193665.00
JQC balance_sheet (annual, 2024-07-31) — Common Stock: 1356093.00
JQC cash_flow (annual, 2024-07-31) — Common Stock Dividend Paid: -86167108.00
JQC balance_sheet (annual, 2024-07-31) — Common Stock Equity: 801035366.00
JQC cash_flow (annual, 2024-07-31) — Common Stock Issuance: 0.00
JQC cash_flow (annual, 2024-07-31) — Common Stock Payments: 0.00
JQC income_statement (annual, 2024-07-31) — Diluted Average Shares: 137444748.00
JQC income_statement (annual, 2024-07-31) — Diluted EPS: 0.71
JQC income_statement (annual, 2024-07-31) — Diluted NI Availto Com Stockholders: 98071171.00
JQC cash_flow (annual, 2024-07-31) — Dividend Paid Cfo: -749903.00
JQC cash_flow (annual, 2024-07-31) — End Cash Position: 277536.00
JQC balance_sheet (annual, 2024-07-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1270357749.00
JQC cash_flow (annual, 2024-07-31) — Financing Cash Flow: -86399249.00
JQC cash_flow (annual, 2024-07-31) — Free Cash Flow: 83205584.00
JQC cash_flow (annual, 2024-07-31) — Gain Loss On Investment Securities: -5501319.00
JQC income_statement (annual, 2024-07-31) — Gain On Sale Of Security: -18940185.00
JQC income_statement (annual, 2024-07-31) — General And Administrative Expense: 2357676.00
JQC income_statement (annual, 2024-07-31) — Interest Expense: 30753085.00
JQC income_statement (annual, 2024-07-31) — Interest Income: 116244827.00
JQC balance_sheet (annual, 2024-07-31) — Invested Capital: 1155643960.00
JQC balance_sheet (annual, 2024-07-31) — Investmentin Financial Assets: 1306990048.00
JQC balance_sheet (annual, 2024-07-31) — Investments And Advances: 1306990048.00
JQC cash_flow (annual, 2024-07-31) — Issuance Of Capital Stock: 0.00
JQC cash_flow (annual, 2024-07-31) — Issuance Of Debt: 0.00
JQC balance_sheet (annual, 2024-07-31) — Long Term Debt And Capital Lease Obligation: 354608594.00
JQC cash_flow (annual, 2024-07-31) — Long Term Debt Issuance: 0.00
JQC cash_flow (annual, 2024-07-31) — Long Term Debt Payments: 0.00
JQC cash_flow (annual, 2024-07-31) — Net Common Stock Issuance: 0.00
JQC balance_sheet (annual, 2024-07-31) — Net Debt: 354331058.00
JQC cash_flow (annual, 2024-07-31) — Net Foreign Currency Exchange Gain Loss: 103.00
JQC income_statement (annual, 2024-07-31) — Net Income: 98071171.00
JQC income_statement (annual, 2024-07-31) — Net Income Common Stockholders: 98071171.00
JQC income_statement (annual, 2024-07-31) — Net Income Continuous Operations: 98071171.00
JQC income_statement (annual, 2024-07-31) — Net Income From Continuing And Discontinued Operation: 98071171.00
JQC income_statement (annual, 2024-07-31) — Net Income From Continuing Operation Net Minority Interest: 98071171.00
JQC cash_flow (annual, 2024-07-31) — Net Income From Continuing Operations: 98071171.00
JQC income_statement (annual, 2024-07-31) — Net Income Including Noncontrolling Interests: 98071171.00
JQC income_statement (annual, 2024-07-31) — Net Interest Income: 85491742.00
JQC cash_flow (annual, 2024-07-31) — Net Issuance Payments Of Debt: 0.00
JQC cash_flow (annual, 2024-07-31) — Net Long Term Debt Issuance: 0.00
JQC cash_flow (annual, 2024-07-31) — Net Other Financing Charges: 0.00
JQC balance_sheet (annual, 2024-07-31) — Net Tangible Assets: 801035366.00
JQC income_statement (annual, 2024-07-31) — Normalized Income: 98071171.00
JQC cash_flow (annual, 2024-07-31) — Operating Cash Flow: 83205584.00
JQC income_statement (annual, 2024-07-31) — Operating Revenue: 100431419.00
JQC balance_sheet (annual, 2024-07-31) — Ordinary Shares Number: 136199996.00
JQC cash_flow (annual, 2024-07-31) — Other Non Cash Items: -6670649.00
JQC income_statement (annual, 2024-07-31) — Other Operating Expenses: 2572.00
JQC balance_sheet (annual, 2024-07-31) — Other Payable: 894404.00
JQC balance_sheet (annual, 2024-07-31) — Payables: 37472494.00
JQC balance_sheet (annual, 2024-07-31) — Preferred Securities Outside Stock Equity: 139215436.00
JQC income_statement (annual, 2024-07-31) — Pretax Income: 98071171.00
JQC balance_sheet (annual, 2024-07-31) — Receivables: 25231820.00
JQC cash_flow (annual, 2024-07-31) — Repayment Of Debt: 0.00
JQC cash_flow (annual, 2024-07-31) — Repurchase Of Capital Stock: 0.00
JQC balance_sheet (annual, 2024-07-31) — Retained Earnings: -339137615.00
JQC income_statement (annual, 2024-07-31) — Selling General And Administration: 2357676.00
JQC balance_sheet (annual, 2024-07-31) — Share Issued: 136199996.00
JQC balance_sheet (annual, 2024-07-31) — Stockholders Equity: 801035366.00
JQC balance_sheet (annual, 2024-07-31) — Tangible Book Value: 801035366.00
JQC income_statement (annual, 2024-07-31) — Tax Effect Of Unusual Items: 0.00
JQC income_statement (annual, 2024-07-31) — Tax Rate For Calcs: 0.21
JQC balance_sheet (annual, 2024-07-31) — Total Assets: 1332796119.00
JQC balance_sheet (annual, 2024-07-31) — Total Capitalization: 1155643960.00
JQC balance_sheet (annual, 2024-07-31) — Total Debt: 354608594.00
JQC balance_sheet (annual, 2024-07-31) — Total Equity Gross Minority Interest: 801035366.00
JQC balance_sheet (annual, 2024-07-31) — Total Liabilities Net Minority Interest: 531760753.00
JQC balance_sheet (quarterly, 2025-01-31) — Accounts Payable: 41807356.00
JQC balance_sheet (quarterly, 2025-01-31) — Additional Paid In Capital: 1138816888.00
JQC balance_sheet (quarterly, 2025-01-31) — Available For Sale Securities: 26667178.00
JQC balance_sheet (quarterly, 2025-01-31) — Capital Stock: 1356093.00
JQC balance_sheet (quarterly, 2025-01-31) — Cash And Cash Equivalents: 16.00
JQC balance_sheet (quarterly, 2025-01-31) — Cash Cash Equivalents And Federal Funds Sold: 16.00
JQC balance_sheet (quarterly, 2025-01-31) — Cash Financial: 16.00
JQC balance_sheet (quarterly, 2025-01-31) — Common Stock: 1356093.00
JQC balance_sheet (quarterly, 2025-01-31) — Common Stock Equity: 796051384.00
JQC balance_sheet (quarterly, 2025-01-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1280325625.00
JQC balance_sheet (quarterly, 2025-01-31) — Invested Capital: 1150925185.00
JQC balance_sheet (quarterly, 2025-01-31) — Investmentin Financial Assets: 1306992803.00
JQC balance_sheet (quarterly, 2025-01-31) — Investments And Advances: 1306992803.00
JQC balance_sheet (quarterly, 2025-01-31) — Long Term Debt And Capital Lease Obligation: 354873801.00
JQC balance_sheet (quarterly, 2025-01-31) — Net Debt: 354873785.00
JQC balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: 796051384.00
JQC balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 136199996.00
JQC balance_sheet (quarterly, 2025-01-31) — Other Payable: 894564.00
JQC balance_sheet (quarterly, 2025-01-31) — Payables: 42701920.00
JQC balance_sheet (quarterly, 2025-01-31) — Preferred Securities Outside Stock Equity: 139265370.00
JQC balance_sheet (quarterly, 2025-01-31) — Receivables: 26101689.00
JQC balance_sheet (quarterly, 2025-01-31) — Retained Earnings: -344121597.00
JQC balance_sheet (quarterly, 2025-01-31) — Share Issued: 136199996.00
JQC balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: 796051384.00
JQC balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: 796051384.00
JQC balance_sheet (quarterly, 2025-01-31) — Total Assets: 1333343503.00
JQC balance_sheet (quarterly, 2025-01-31) — Total Capitalization: 1150925185.00
JQC balance_sheet (quarterly, 2025-01-31) — Total Debt: 354873801.00
JQC balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: 796051384.00
JQC balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 537292119.00
JQC income_statement (annual, 2025-07-31) — Basic Average Shares: 159966665.00
JQC income_statement (annual, 2025-07-31) — Basic EPS: 0.40
JQC income_statement (annual, 2025-07-31) — Diluted Average Shares: 159966665.00
JQC income_statement (annual, 2025-07-31) — Diluted EPS: 0.40
JQC balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 95951307.00
JQC balance_sheet (quarterly, 2026-01-31) — Additional Paid In Capital: 1179326020.00
JQC balance_sheet (quarterly, 2026-01-31) — Available For Sale Securities: 82579358.00
JQC balance_sheet (quarterly, 2026-01-31) — Capital Stock: 1478167.00
JQC balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 118720.00
JQC balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Federal Funds Sold: 118720.00
JQC balance_sheet (quarterly, 2026-01-31) — Cash Financial: 118720.00
JQC balance_sheet (quarterly, 2026-01-31) — Common Stock: 1478167.00
JQC balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 812453156.00
JQC balance_sheet (quarterly, 2026-01-31) — Derivative Product Liabilities: 0.00
JQC balance_sheet (quarterly, 2026-01-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1274388222.00
JQC balance_sheet (quarterly, 2026-01-31) — Invested Capital: 1168511780.00
JQC balance_sheet (quarterly, 2026-01-31) — Investmentin Financial Assets: 1356967580.00
JQC balance_sheet (quarterly, 2026-01-31) — Investments And Advances: 1356967580.00
JQC balance_sheet (quarterly, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 356058624.00
JQC balance_sheet (quarterly, 2026-01-31) — Net Debt: 355939904.00
JQC balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: 812453156.00
JQC balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 147816679.00
JQC balance_sheet (quarterly, 2026-01-31) — Other Payable: 140273355.00
JQC balance_sheet (quarterly, 2026-01-31) — Payables: 236224662.00
JQC balance_sheet (quarterly, 2026-01-31) — Receivables: 48037871.00
JQC balance_sheet (quarterly, 2026-01-31) — Retained Earnings: -368351031.00
JQC balance_sheet (quarterly, 2026-01-31) — Share Issued: 147816679.00
JQC balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 812453156.00
JQC balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: 812453156.00
JQC balance_sheet (quarterly, 2026-01-31) — Total Assets: 1405360918.00
JQC balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 1168511780.00
JQC balance_sheet (quarterly, 2026-01-31) — Total Debt: 356058624.00
JQC balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 812453156.00
JQC balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 592907762.00
JRI balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 5448425.00
JRI income_statement (annual, 2022-12-31) — +Operating Expense: 2046159.00
JRI income_statement (annual, 2022-12-31) — +Total Revenue: -71622503.00
JRI balance_sheet (annual, 2022-12-31) — Accounts Payable: 1801771.00
JRI balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 588178318.00
JRI balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 21740347.00
JRI income_statement (annual, 2022-12-31) — Basic Average Shares: 27744409.00
JRI income_statement (annual, 2022-12-31) — Basic EPS: -2.66
JRI cash_flow (annual, 2022-12-31) — Beginning Cash Position: 3380096.00
JRI balance_sheet (annual, 2022-12-31) — Capital Stock: 274537.00
JRI balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 323049.00
JRI balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 323049.00
JRI cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -31791360.00
JRI balance_sheet (annual, 2022-12-31) — Cash Financial: 323049.00
JRI cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -450601.00
JRI cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 14527.00
JRI cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 0.00
JRI cash_flow (annual, 2022-12-31) — Change In Payable: -1922815.00
JRI cash_flow (annual, 2022-12-31) — Change In Receivables: -994321.00
JRI cash_flow (annual, 2022-12-31) — Change In Working Capital: -3353210.00
JRI cash_flow (annual, 2022-12-31) — Changes In Cash: -3057047.00
JRI balance_sheet (annual, 2022-12-31) — Common Stock: 274537.00
JRI cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -31791360.00
JRI balance_sheet (annual, 2022-12-31) — Common Stock Equity: 372451403.00
JRI income_statement (annual, 2022-12-31) — Diluted Average Shares: 27744409.00
JRI income_statement (annual, 2022-12-31) — Diluted EPS: -2.66
JRI income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -73668662.00
JRI cash_flow (annual, 2022-12-31) — End Cash Position: 323049.00
JRI balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 511981383.00
JRI cash_flow (annual, 2022-12-31) — Financing Cash Flow: -57598405.00
JRI cash_flow (annual, 2022-12-31) — Free Cash Flow: 54541358.00
JRI cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 131528177.00
JRI income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -15844092.00
JRI income_statement (annual, 2022-12-31) — General And Administrative Expense: 882419.00
JRI income_statement (annual, 2022-12-31) — Interest Expense: 4364883.00
JRI income_statement (annual, 2022-12-31) — Interest Income: 9818473.00
JRI balance_sheet (annual, 2022-12-31) — Invested Capital: 539491897.00
JRI balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 539434037.00
JRI balance_sheet (annual, 2022-12-31) — Investments And Advances: 539434037.00
JRI cash_flow (annual, 2022-12-31) — Issuance Of Debt: 55494.00
JRI balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 167040494.00
JRI cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 55494.00
JRI cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -30950000.00
JRI balance_sheet (annual, 2022-12-31) — Net Debt: 166717445.00
JRI income_statement (annual, 2022-12-31) — Net Income: -73668662.00
JRI income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -73668662.00
JRI income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -73668662.00
JRI income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -73668662.00
JRI income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -73668662.00
JRI cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -73668662.00
JRI income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -73668662.00
JRI income_statement (annual, 2022-12-31) — Net Interest Income: 5453590.00
JRI cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -30894506.00
JRI cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -30894506.00
JRI cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 5087461.00
JRI balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 372451403.00
JRI income_statement (annual, 2022-12-31) — Normalized Income: -73668662.00
JRI cash_flow (annual, 2022-12-31) — Operating Cash Flow: 54541358.00
JRI income_statement (annual, 2022-12-31) — Operating Revenue: -71622503.00
JRI balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 27709459.00
JRI cash_flow (annual, 2022-12-31) — Other Non Cash Items: 35053.00
JRI income_statement (annual, 2022-12-31) — Other Operating Expenses: 1163740.00
JRI balance_sheet (annual, 2022-12-31) — Other Payable: 5087461.00
JRI balance_sheet (annual, 2022-12-31) — Payables: 6889232.00
JRI income_statement (annual, 2022-12-31) — Pretax Income: -73668662.00
JRI balance_sheet (annual, 2022-12-31) — Receivables: 7447509.00
JRI cash_flow (annual, 2022-12-31) — Repayment Of Debt: -30950000.00
JRI balance_sheet (annual, 2022-12-31) — Retained Earnings: -216001452.00
JRI income_statement (annual, 2022-12-31) — Selling General And Administration: 882419.00
JRI balance_sheet (annual, 2022-12-31) — Share Issued: 27709459.00
JRI balance_sheet (annual, 2022-12-31) — Stockholders Equity: 372451403.00
JRI balance_sheet (annual, 2022-12-31) — Tangible Book Value: 372451403.00
JRI income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
JRI income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
JRI balance_sheet (annual, 2022-12-31) — Total Assets: 547240877.00
JRI balance_sheet (annual, 2022-12-31) — Total Capitalization: 539491897.00
JRI balance_sheet (annual, 2022-12-31) — Total Debt: 167040494.00
JRI balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 372451403.00
JRI balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 174789474.00
JRI income_statement (annual, 2023-12-31) — +Operating Expense: 1593175.00
JRI income_statement (annual, 2023-12-31) — +Total Revenue: 34394545.00
JRI balance_sheet (annual, 2023-12-31) — Accounts Payable: 981488.00
JRI balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 576038573.00
JRI balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 19950000.00
JRI income_statement (annual, 2023-12-31) — Basic Average Shares: 27589144.00
JRI income_statement (annual, 2023-12-31) — Basic EPS: 1.19
JRI cash_flow (annual, 2023-12-31) — Beginning Cash Position: 323049.00
JRI balance_sheet (annual, 2023-12-31) — Capital Stock: 274167.00
JRI balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 244586.00
JRI balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 244586.00
JRI cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -29520364.00
JRI balance_sheet (annual, 2023-12-31) — Cash Financial: 244586.00
JRI cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -134191.00
JRI cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -5741.00
JRI cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 0.00
JRI cash_flow (annual, 2023-12-31) — Change In Payable: -840388.00
JRI cash_flow (annual, 2023-12-31) — Change In Receivables: 2690092.00
JRI cash_flow (annual, 2023-12-31) — Change In Working Capital: 1709772.00
JRI cash_flow (annual, 2023-12-31) — Changes In Cash: -78463.00
JRI balance_sheet (annual, 2023-12-31) — Common Stock: 274167.00
JRI cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -29520364.00
JRI balance_sheet (annual, 2023-12-31) — Common Stock Equity: 375319185.00
JRI cash_flow (annual, 2023-12-31) — Common Stock Payments: -413224.00
JRI balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 0.00
JRI income_statement (annual, 2023-12-31) — Diluted Average Shares: 27589144.00
JRI income_statement (annual, 2023-12-31) — Diluted EPS: 1.19
JRI income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 32801370.00
JRI cash_flow (annual, 2023-12-31) — End Cash Position: 244586.00
JRI balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 505214945.00
JRI cash_flow (annual, 2023-12-31) — Financing Cash Flow: -44859156.00
JRI cash_flow (annual, 2023-12-31) — Free Cash Flow: 44780693.00
JRI cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 9617935.00
JRI income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -15427366.00
JRI income_statement (annual, 2023-12-31) — General And Administrative Expense: 594168.00
JRI income_statement (annual, 2023-12-31) — Interest Expense: 9241727.00
JRI income_statement (annual, 2023-12-31) — Interest Income: 11592163.00
JRI balance_sheet (annual, 2023-12-31) — Invested Capital: 529058792.00
JRI balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 529164486.00
JRI balance_sheet (annual, 2023-12-31) — Investments And Advances: 529164486.00
JRI cash_flow (annual, 2023-12-31) — Issuance Of Debt: 2044607.00
JRI balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 153739607.00
JRI cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 2044607.00
JRI cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -15345494.00
JRI cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -413224.00
JRI balance_sheet (annual, 2023-12-31) — Net Debt: 153495021.00
JRI cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 749479.00
JRI income_statement (annual, 2023-12-31) — Net Income: 32801370.00
JRI income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 32801370.00
JRI income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 32801370.00
JRI income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 32801370.00
JRI income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 32801370.00
JRI cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 32801370.00
JRI income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 32801370.00
JRI income_statement (annual, 2023-12-31) — Net Interest Income: 2350436.00
JRI cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -13300887.00
JRI cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -13300887.00
JRI cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -1624681.00
JRI balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 375319185.00
JRI income_statement (annual, 2023-12-31) — Normalized Income: 32801370.00
JRI cash_flow (annual, 2023-12-31) — Operating Cash Flow: 44780693.00
JRI income_statement (annual, 2023-12-31) — Operating Revenue: 34394545.00
JRI balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 27672113.00
JRI cash_flow (annual, 2023-12-31) — Other Non Cash Items: -97907.00
JRI income_statement (annual, 2023-12-31) — Other Operating Expenses: 999007.00
JRI balance_sheet (annual, 2023-12-31) — Other Payable: 3462780.00
JRI balance_sheet (annual, 2023-12-31) — Payables: 4444268.00
JRI income_statement (annual, 2023-12-31) — Pretax Income: 32801370.00
JRI balance_sheet (annual, 2023-12-31) — Receivables: 4757417.00
JRI cash_flow (annual, 2023-12-31) — Repayment Of Debt: -15345494.00
JRI cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -413224.00
JRI balance_sheet (annual, 2023-12-31) — Retained Earnings: -200993555.00
JRI income_statement (annual, 2023-12-31) — Selling General And Administration: 594168.00
JRI balance_sheet (annual, 2023-12-31) — Share Issued: 27672113.00
JRI balance_sheet (annual, 2023-12-31) — Stockholders Equity: 375319185.00
JRI balance_sheet (annual, 2023-12-31) — Tangible Book Value: 375319185.00
JRI income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
JRI income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
JRI balance_sheet (annual, 2023-12-31) — Total Assets: 534208512.00
JRI balance_sheet (annual, 2023-12-31) — Total Capitalization: 529058792.00
JRI balance_sheet (annual, 2023-12-31) — Total Debt: 153739607.00
JRI balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 375319185.00
JRI balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 158889327.00
JRI income_statement (annual, 2024-12-31) — +Operating Expense: 2061621.00
JRI income_statement (annual, 2024-12-31) — +Total Revenue: 27569236.00
JRI balance_sheet (annual, 2024-12-31) — Accounts Payable: 3572746.00
JRI balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 3572746.00
JRI balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 555068795.00
JRI balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 555068795.00
JRI balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 12425000.00
JRI balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 12425000.00
JRI income_statement (annual, 2024-12-31) — Basic Average Shares: 27683079.00
JRI income_statement (annual, 2024-12-31) — Basic EPS: 0.92
JRI cash_flow (annual, 2024-12-31) — Beginning Cash Position: 244586.00
JRI balance_sheet (annual, 2024-12-31) — Capital Stock: 274167.00
JRI balance_sheet (quarterly, 2024-12-31) — Capital Stock: 274167.00
JRI balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 2126298.00
JRI balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 2126298.00
JRI balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 2126298.00
JRI balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 2126298.00
JRI cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -39329227.00
JRI balance_sheet (annual, 2024-12-31) — Cash Financial: 2126298.00
JRI balance_sheet (quarterly, 2024-12-31) — Cash Financial: 2126298.00
JRI cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -55022.00
JRI cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 13205.00
JRI cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 0.00
JRI cash_flow (annual, 2024-12-31) — Change In Payable: 2612828.00
JRI cash_flow (annual, 2024-12-31) — Change In Receivables: -298204.00
JRI cash_flow (annual, 2024-12-31) — Change In Working Capital: 2272807.00
JRI cash_flow (annual, 2024-12-31) — Changes In Cash: 1881712.00
JRI balance_sheet (annual, 2024-12-31) — Common Stock: 274167.00
JRI balance_sheet (quarterly, 2024-12-31) — Common Stock: 274167.00
JRI cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -39329227.00
JRI balance_sheet (annual, 2024-12-31) — Common Stock Equity: 361497573.00
JRI balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 361497573.00
JRI balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 0.00
JRI balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 0.00
JRI income_statement (annual, 2024-12-31) — Diluted Average Shares: 27683079.00
JRI income_statement (annual, 2024-12-31) — Diluted EPS: 0.92
JRI income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 25507615.00
JRI cash_flow (annual, 2024-12-31) — End Cash Position: 2126298.00
JRI balance_sheet (annual, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 528777669.00
JRI balance_sheet (quarterly, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 528777669.00
JRI cash_flow (annual, 2024-12-31) — Financing Cash Flow: -12283330.00
JRI cash_flow (annual, 2024-12-31) — Free Cash Flow: 14165042.00
JRI cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -13671472.00
JRI income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 11469319.00
JRI income_statement (annual, 2024-12-31) — General And Administrative Expense: 1098473.00
JRI income_statement (annual, 2024-12-31) — Interest Expense: 9240046.00
JRI income_statement (annual, 2024-12-31) — Interest Income: 12674013.00
JRI balance_sheet (annual, 2024-12-31) — Invested Capital: 544520091.00
JRI balance_sheet (quarterly, 2024-12-31) — Invested Capital: 544520091.00
JRI balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 542779866.00
JRI balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 542779866.00
JRI balance_sheet (annual, 2024-12-31) — Investments And Advances: 542779866.00
JRI balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 542779866.00
JRI cash_flow (annual, 2024-12-31) — Issuance Of Debt: 29282911.00
JRI balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 183022518.00
JRI balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 183022518.00
JRI cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 29282911.00
JRI cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
JRI balance_sheet (annual, 2024-12-31) — Net Debt: 180896220.00
JRI balance_sheet (quarterly, 2024-12-31) — Net Debt: 180896220.00
JRI cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 209394.00
JRI income_statement (annual, 2024-12-31) — Net Income: 25507615.00
JRI income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 25507615.00
JRI income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 25507615.00
JRI income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 25507615.00
JRI income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 25507615.00
JRI cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 25507615.00
JRI income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 25507615.00
JRI income_statement (annual, 2024-12-31) — Net Interest Income: 3433967.00
JRI cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 29282911.00
JRI cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 29282911.00
JRI cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -2237014.00
JRI balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 361497573.00
JRI balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 361497573.00
JRI income_statement (annual, 2024-12-31) — Normalized Income: 25507615.00
JRI cash_flow (annual, 2024-12-31) — Operating Cash Flow: 14165042.00
JRI income_statement (annual, 2024-12-31) — Operating Revenue: 27569236.00
JRI balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 27672113.00
JRI balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 27672113.00
JRI cash_flow (annual, 2024-12-31) — Other Non Cash Items: -181227.00
JRI income_statement (annual, 2024-12-31) — Other Operating Expenses: 963148.00
JRI balance_sheet (annual, 2024-12-31) — Other Payable: 1669753.00
JRI balance_sheet (quarterly, 2024-12-31) — Other Payable: 1669753.00
JRI balance_sheet (annual, 2024-12-31) — Payables: 5242499.00
JRI balance_sheet (quarterly, 2024-12-31) — Payables: 5242499.00
JRI income_statement (annual, 2024-12-31) — Pretax Income: 25507615.00
JRI balance_sheet (annual, 2024-12-31) — Receivables: 5055621.00
JRI balance_sheet (quarterly, 2024-12-31) — Receivables: 5055621.00
JRI cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
JRI balance_sheet (annual, 2024-12-31) — Retained Earnings: -193845389.00
JRI balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -193845389.00
JRI income_statement (annual, 2024-12-31) — Selling General And Administration: 1098473.00
JRI balance_sheet (annual, 2024-12-31) — Share Issued: 27672113.00
JRI balance_sheet (quarterly, 2024-12-31) — Share Issued: 27672113.00
JRI balance_sheet (annual, 2024-12-31) — Stockholders Equity: 361497573.00
JRI balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 361497573.00
JRI balance_sheet (annual, 2024-12-31) — Tangible Book Value: 361497573.00
JRI balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 361497573.00
JRI income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
JRI income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
JRI balance_sheet (annual, 2024-12-31) — Total Assets: 549990603.00
JRI balance_sheet (quarterly, 2024-12-31) — Total Assets: 549990603.00
JRI balance_sheet (annual, 2024-12-31) — Total Capitalization: 544520091.00
JRI balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 544520091.00
JRI balance_sheet (annual, 2024-12-31) — Total Debt: 183022518.00
JRI balance_sheet (quarterly, 2024-12-31) — Total Debt: 183022518.00
JRI balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 361497573.00
JRI balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 361497573.00
JRI balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 188493030.00
JRI balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 188493030.00
JRI balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 9539550.00
JRI balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 555068795.00
JRI balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 3650000.00
JRI balance_sheet (quarterly, 2025-06-30) — Capital Stock: 274167.00
JRI balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 3680818.00
JRI balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 3680818.00
JRI balance_sheet (quarterly, 2025-06-30) — Cash Financial: 3680818.00
JRI balance_sheet (quarterly, 2025-06-30) — Common Stock: 274167.00
JRI balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 371865487.00
JRI balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 0.00
JRI balance_sheet (quarterly, 2025-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 534783392.00
JRI balance_sheet (quarterly, 2025-06-30) — Invested Capital: 542810487.00
JRI balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 538699105.00
JRI balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 538699105.00
JRI balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 170945000.00
JRI balance_sheet (quarterly, 2025-06-30) — Net Debt: 167264182.00
JRI balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 371865487.00
JRI balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 27672113.00
JRI balance_sheet (quarterly, 2025-06-30) — Other Payable: 449877.00
JRI balance_sheet (quarterly, 2025-06-30) — Payables: 9989427.00
JRI balance_sheet (quarterly, 2025-06-30) — Receivables: 10739510.00
JRI balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -183477475.00
JRI balance_sheet (quarterly, 2025-06-30) — Share Issued: 27672113.00
JRI balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 371865487.00
JRI balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 371865487.00
JRI balance_sheet (quarterly, 2025-06-30) — Total Assets: 553147420.00
JRI balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 542810487.00
JRI balance_sheet (quarterly, 2025-06-30) — Total Debt: 170945000.00
JRI balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 371865487.00
JRI balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 181281933.00
JRI balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 0.00
JRI income_statement (annual, 2025-12-31) — +Operating Expense: 1273629.00
JRI income_statement (annual, 2025-12-31) — +Total Revenue: 50384846.00
JRI balance_sheet (annual, 2025-12-31) — Accounts Payable: 1701298.00
JRI balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1701298.00
JRI balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 533129317.00
JRI balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 533129317.00
JRI balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 9125000.00
JRI balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 9125000.00
JRI income_statement (annual, 2025-12-31) — Basic Average Shares: 27847626.00
JRI income_statement (annual, 2025-12-31) — Basic EPS: 1.76
JRI cash_flow (annual, 2025-12-31) — Beginning Cash Position: 2126298.00
JRI balance_sheet (annual, 2025-12-31) — Capital Stock: 274401.00
JRI balance_sheet (quarterly, 2025-12-31) — Capital Stock: 274401.00
JRI balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 889782.00
JRI balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 889782.00
JRI balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 1032551.00
JRI balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 1032551.00
JRI cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -43611498.00
JRI balance_sheet (annual, 2025-12-31) — Cash Financial: 889782.00
JRI balance_sheet (quarterly, 2025-12-31) — Cash Financial: 889782.00
JRI cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 109989.00
JRI cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 4979.00
JRI cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 0.00
JRI cash_flow (annual, 2025-12-31) — Change In Payable: -1880246.00
JRI cash_flow (annual, 2025-12-31) — Change In Receivables: 89213.00
JRI cash_flow (annual, 2025-12-31) — Change In Working Capital: -1676065.00
JRI cash_flow (annual, 2025-12-31) — Changes In Cash: -1093747.00
JRI balance_sheet (annual, 2025-12-31) — Common Stock: 274401.00
JRI balance_sheet (quarterly, 2025-12-31) — Common Stock: 274401.00
JRI cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -43611498.00
JRI balance_sheet (annual, 2025-12-31) — Common Stock Equity: 366997292.00
JRI balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 366997292.00
JRI balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 0.00
JRI balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 0.00
JRI income_statement (annual, 2025-12-31) — Diluted Average Shares: 27847626.00
JRI income_statement (annual, 2025-12-31) — Diluted EPS: 1.76
JRI income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 49111217.00
JRI cash_flow (annual, 2025-12-31) — End Cash Position: 1032551.00
JRI balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 528450385.00
JRI balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 528450385.00
JRI cash_flow (annual, 2025-12-31) — Financing Cash Flow: -53733380.00
JRI cash_flow (annual, 2025-12-31) — Free Cash Flow: 52639633.00
JRI cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 5423500.00
JRI income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 12281610.00
JRI income_statement (annual, 2025-12-31) — General And Administrative Expense: 534943.00
JRI income_statement (annual, 2025-12-31) — Interest Expense: 8598323.00
JRI income_statement (annual, 2025-12-31) — Interest Income: 13903671.00
JRI balance_sheet (annual, 2025-12-31) — Invested Capital: 541123694.00
JRI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 541123694.00
JRI balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 537575385.00
JRI balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 537575385.00
JRI balance_sheet (annual, 2025-12-31) — Investments And Advances: 537575385.00
JRI balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 537575385.00
JRI cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
JRI balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 174126402.00
JRI balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 174126402.00
JRI cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
JRI cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -8896116.00
JRI balance_sheet (annual, 2025-12-31) — Net Debt: 173236620.00
JRI balance_sheet (quarterly, 2025-12-31) — Net Debt: 173236620.00
JRI cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -64928.00
JRI income_statement (annual, 2025-12-31) — Net Income: 49111217.00
JRI income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 49111217.00
JRI income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 49111217.00
JRI income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 49111217.00
JRI income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 49111217.00
JRI cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 49111217.00
JRI income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 49111217.00
JRI income_statement (annual, 2025-12-31) — Net Interest Income: 5305348.00
JRI cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -8896116.00
JRI cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -8896116.00
JRI cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1225766.00
JRI balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 366997292.00
JRI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 366997292.00
JRI income_statement (annual, 2025-12-31) — Normalized Income: 49111217.00
JRI cash_flow (annual, 2025-12-31) — Operating Cash Flow: 52639633.00
JRI income_statement (annual, 2025-12-31) — Operating Revenue: 50384846.00
JRI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 27695723.00
JRI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 27695723.00
JRI cash_flow (annual, 2025-12-31) — Other Non Cash Items: -157948.00
JRI income_statement (annual, 2025-12-31) — Other Operating Expenses: 738686.00
JRI balance_sheet (annual, 2025-12-31) — Other Payable: 435189.00
JRI balance_sheet (quarterly, 2025-12-31) — Other Payable: 435189.00
JRI balance_sheet (annual, 2025-12-31) — Payables: 2136487.00
JRI balance_sheet (quarterly, 2025-12-31) — Payables: 2136487.00